If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAPP.L Regulatory News (APP)

  • There is currently no data for APP

Rule 8.3- African Platinum

21 Feb 2007 15:13

UBS AG21 February 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATIONName of person dealing (Note 1) UBS AG London Branch Company dealt in African Platinum PlcClass of relevant security to which the dealings Ord 0.1pbeing disclosed relate (Note 2)Date of dealing 20 February 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 18,896,807 3.97% 0 0.00%(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 18,896,807 3.97% 0 0.00% (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) PURCHASE 32,600 54.5p PURCHASE 967,400 54.5 PURCHASE 176,496 54.5 PURCHASE 50,000 54.5 PURCHASE 250,000 54.5 PURCHASE 500,000 54.5 (b) Derivatives transactions (other than options) Product name, Long/short (Note Number of securities Price per unit e.g. CFD 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/ call purchasing, to which European received option varying etc. the option etc. per unit relates (Note 5) (Note 7) (ii) ExercisingProduct name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 21 February 2007 Contact name JOSEPH EVANS Telephone number 020 7567 8286 If a connected EFM, name of offeree/offeror with N/Awhich connectedIf a connected EFM, state nature of connection N/A(Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Feb 20238:35 amRNSForm 8.5 (EPT/RI)
31st Jan 20233:30 pmRNSForm 8.3 - APP LN
31st Jan 20239:41 amRNSForm 8.3 - Appreciate Group
30th Jan 20233:30 pmRNSForm 8.3 - APP LN
30th Jan 20231:18 pmRNSForm 8.3 - Appreciate Group PLC
30th Jan 20239:21 amRNSForm 8.5 (EPT/RI)
27th Jan 20239:59 amRNSForm 8.3 - APPRECIATE GROUP PLC
26th Jan 20239:15 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
25th Jan 202311:50 amRNSNotice of Court Hearing
25th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
25th Jan 20238:05 amRNSForm 8.3 - APPRECIATE GROUP PLC
24th Jan 202311:11 amRNSForm 8.3 - APPRECIATE GROUP PLC
24th Jan 20238:42 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
23rd Jan 20239:53 amRNSForm 8.5 (EPT/RI)
23rd Jan 20238:37 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
20th Jan 20234:40 pmRNSResult of Court Meeting and General Meeting
20th Jan 20239:17 amRNSForm 8.5 (EPT/RI)
20th Jan 20239:07 amRNSForm 8.5 (EPT/NON-RI) Appreciate Group Plc
19th Jan 20233:03 pmRNSForm 8.3 - APPRECIATE GROUP PLC
19th Jan 20238:53 amRNSForm 8.5 (EPT/RI)
19th Jan 20237:01 amRNSFCA Approval and Timetable Update
18th Jan 20234:11 pmRNSForm 8.3 - Appreciate Group
18th Jan 202310:07 amRNSForm 8.5 (EPT/RI)
17th Jan 20233:38 pmRNSHolding(s) in Company
17th Jan 20233:03 pmRNSForm 8.3 - APPRECIATE GROUP PLC
13th Jan 202311:07 amRNSForm 8.5 (EPT/RI)
13th Jan 20237:00 amRNSQ3 FY 2023 Trading Update
11th Jan 20231:14 pmRNSHolding(s) in Company
9th Jan 202311:50 amRNSForm 8.3 - Appreciate Group PLC
9th Jan 20238:41 amRNSForm 8.5 (EPT/RI)
5th Jan 20237:00 amRNSDirectorate Change
30th Dec 20228:41 amRNSForm 8.5 (EPT/RI)
28th Dec 20227:00 amRNSForm 8.3 - APPRECIATE GROUP PLC
23rd Dec 20221:25 pmRNSForm 8.3 - APPRECIATE GROUP PLC
21st Dec 20224:33 pmRNSForm 8.3 - Appreciate Group plc
21st Dec 20224:30 pmRNSForm 8.3 - Appreciate Group plc
20th Dec 20228:32 amRNSForm 8.5 (EPT/RI)
19th Dec 20223:25 pmRNSForm 8.3 - Appreciate Group PLC
19th Dec 20223:19 pmRNSHolding(s) in Company
19th Dec 20223:13 pmRNSHolding(s) in Company
19th Dec 20223:05 pmRNSForm 8.3 - APPRECIATE GROUP PLC
19th Dec 20222:08 pmRNSHolding(s) in Company
19th Dec 20229:23 amRNSForm 8.3 - APPRECIATE GROUP PLC
15th Dec 20221:29 pmRNSReplace - Form 8.3 - APPRECIATE GRP PLC
14th Dec 20224:27 pmRNSHolding(s) in Company
14th Dec 20222:17 pmRNSHolding(s) in Company
14th Dec 20228:53 amRNSForm 8.5 (EPT/RI)
13th Dec 20229:06 amRNSForm 8.5 (EPT/RI)
13th Dec 20228:16 amRNSForm 8.3 - Appreciate Group PLC
12th Dec 202211:41 amRNSForm 8.3 - Appreciate Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.